This ought to be taken into consideration in the treatment of ADA deficiency; all three treatments of ERT, BMT, and GT achieve near-complete corrections of bone abnormalities in mice, yet this efficiency is not entirely replicated in patients. This evidence concerns the gene ADA and hyperinsulinemic hypoglycemia, familial, 4.